13/02/04

Tuberculosis vaccine gets massive cash boost

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:

You have to credit our authors.
You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
The easiest way to get the article on your site is to embed the code below.

For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

<div class="article-wrap">
<div id="article-introduction">
<h1>Tuberculosis vaccine gets massive cash boost</h1>
<h4></h4>
</div>
<br />
<br />

<div id="article-body">
<p><P>The Bill and Melinda Gates Foundation has donated US$82.9 million to support the development of a new tuberculosis (TB) vaccine. The cash injection more than doubles the annual amount spent on TB vaccines worldwide.</P><br />
<P>Globally, 2 billion people are infected with TB, and 2 million die from it every year. It is rife in developing countries but also on the rise in Europe and North America.</P><br />
<P>The new vaccine, a variant of the Bacille Calmette-Guérin (BCG) type, will undergo a nine-month trial in volunteers at a centre in North Carolina, United States. The money will also be used to push existing vaccines through clinical trials, and assist in the development of next-generation treatments.</P><br />
<P><a  href="http://www.nature.com/nsu/040209/040209-14.html" target="_blank" onclick="pageTracker._trackPageview('/tracking/external/'+this.href);" rel="noopener noreferrer">Link to news story in Nature Science Update</A></P></p>

</div>
<div class="quick-links-wrapper">
<h3>You might also like</h3>
[related-articles]
</div>
<p>This article was originally published on <a href="https://www.scidev.net" target="_blank">SciDev.Net</a>. Read the <a href="https://www.scidev.net/global/news/tuberculosis-vaccine-gets-massive-cash-boost/" target="_blank">original article</a>.</p>
<script type="text/javascript">
(function(e,t,n,r,i,s,o){e["GoogleAnalyticsObject"]=i;e[i]=e[i]||function(){(e[i].q=e[i].q||[]).push(arguments)},e[i].l=1*new Date;s=t.createElement(n),o=t.getElementsByTagName(n)[0];s.async=1;s.src=r;o.parentNode.insertBefore(s,o)})(window,document,"script","//www.google-analytics.com/ga.js","ga");var _gaq=_gaq||[];var _gaq=_gaq||[];_gaq.push(["_setAccount","UA-3223906-8"],["_trackEvent","article interaction","republished","https://www.scidev.net/global/news/tuberculosis-vaccine-gets-massive-cash-boost/",null,true])
</script>
</div>

The Bill and Melinda Gates Foundation has donated US$82.9 million to support the development of a new tuberculosis (TB) vaccine. The cash injection more than doubles the annual amount spent on TB vaccines worldwide.

Globally, 2 billion people are infected with TB, and 2 million die from it every year. It is rife in developing countries but also on the rise in Europe and North America.

The new vaccine, a variant of the Bacille Calmette-Guérin (BCG) type, will undergo a nine-month trial in volunteers at a centre in North Carolina, United States. The money will also be used to push existing vaccines through clinical trials, and assist in the development of next-generation treatments.

Link to news story in Nature Science Update